Terms ending in 2040
Musc Foundation for Research Development
Every in-force patent on Musc Foundation for Research Development's record whose computed term ends in 2040, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 11,771,893 | Motion-Activated, Closed-Loop Non-Invasive Vagus Nerve Stimulation for Neurorehabilitation In force · High confidence | Musc Foundation for Research Development | In force | High confidence | |
| US 11,065,033 | Minimally Invasive Subdural Evacuating System In force · High confidence | Musc Foundation for Research Development | In force | High confidence | |
| US 12,108,965 | Minimally Invasive Subdural Evacuating System In force · High confidence | MUSC Foundation for Research Development | In force | High confidence | |
| US 12,721,881 | Endostatin Peptides for the Treatment of Tumors, Fibrosis and Acute Lung Injury In force · Medium confidence | Musc Foundation for Research Development | In force | Medium confidence | |
| US 12,653,573 | Minimally Invasive Subdural Evacuating System In force · High confidence | MUSC Foundation for Research Development | In force | High confidence | |
| US 11,464,740 | Method and Devices for Delivering Therapeutics by Oral, Respiratory, Mucosal, Transdermal Routes In force · High confidence | Musc Foundation for Research Development | In force | High confidence |
6 of 6 patents shown. Soonest term end first, then patent number.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.